“…Characterization of the physical properties of the active pharmaceutical ingredient (API) is essential for the manufacture of solid dosage forms, as these physical properties can affect the manufacturability, stability, and efficacy of the solid dosage form. The physical properties of APIs have been evaluated by many methods, [1][2][3][4][5][6][7][8] such as X-ray powder diffraction (XRPD), thermal analysis, dynamic vapor sorption, Fourier transform IR spectroscopy, Raman spectroscopy, and solid-state NMR. We have reported on a new method for API, X-ray absorption near-edge structure (XANES) spectroscopy.…”